Cannabidiol Oral Solution [Epidiolex]
JZP926-402
Approved small_molecule completed
Quick answer
Cannabidiol Oral Solution [Epidiolex] for Tuberous Sclerosis Complex Associated Neuropsychiatric Disease is a Approved program (small_molecule) at Jazz Pharmaceuticals plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Jazz Pharmaceuticals plc
- Indication
- Tuberous Sclerosis Complex Associated Neuropsychiatric Disease
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed